Kappa Bioscience, maker of K2VITAL® vitamin K2 MK-7, is the pioneer in the development and production of exceptionally pure all-trans menaquinone-7 (K2 MK-7) produced by organic synthesis. K2VITAL® is 99.7% biologically active MK-7 produced in Norway. Protected, microencapsulated K2VITAL® DELTA is Kappa's market-leading solution to K2 stability and compliant consumer products. Unprotected K2 is not stable when formulated with minerals, and DELTA ensures stability and delivery of K2 label claim. The K2VITAL® product portfolio offers a full range of forms and concentrations designed to maximize product ROI.
Vitamin K2 MK-7 is an essential vitamin that balances calcium in the body. K2VITAL® promotes Bone Health by activating osteocalcin proteins that integrates calcium into bone. K2 also promotes Cardiovascular Health by activating matrix-Gla proteins (MGP) which prevent excess calcium from deposit in the heart and arteries.
Innovative solutions like Kappa's white-label products LookBook and ExperienceCard programs speed time-to-market and increase returns. Vitamin K2 serves all consumer types in several market categories, offering exceptional commercial opportunity.